Φορτώνει......
New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
In the last decades, the increasing evidence concerning inflammation mechanisms underlying severe eosinophilic asthma has highlighted new potential therapeutic targets and has paved the way to new selective biologic drugs. Understanding the mechanism of action and the clinical outcomes of a particul...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Biologics |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6535408/ https://ncbi.nlm.nih.gov/pubmed/31190733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S157183 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|